Chronic Liver Failure after Treatment with Infliximab for Ankylosing Spondylitis in a Patient with Hepatitis B
A 50-year-old man with ankylosing spondylitis was treated successfully with infliximab, who was also a HBV carrier for about twenty five years. After injection with infliximab for four times, he developed jaundice and HBV DNA was detectable in serum. Serum aminotransferase and total bilirubin levels...
Main Authors: | Li Yun-ru, Chen Feng-xin, Duan Xue-fei, Gao Xue-song, Fan Xiao-ling |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2013-06-01
|
Series: | Infection International |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/ii.2013.2.issue-2/ii-2017-0045/ii-2017-0045.xml?format=INT |
Similar Items
-
Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
by: Tatyana Valentinovna Mezenova, et al.
Published: (2012-04-01) -
The effect of infliximab on depressive symptoms in patients with ankylosing spondylitis
by: Emine Duygu Ersözlü-Bozkırlı, et al.
Published: (2015-07-01) -
The efficacy and safety of infliximab in patients with ankylosing spondylitis: results of an open-labeled multicenter study
by: Nikolay Vasil'evich Bunchuk, et al.
Published: (2010-10-01) -
Experience with long-term infliximab therapy in patients with ankylosing spondylitis
by: Oksana Alekseevna Rumyantseva, et al.
Published: (2010-12-01) -
Ankylosing Spondylitis
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01)